Target haemoglobin in the treatment of anaemia of chronic renal failure by recombinant human erythropoietin

Effect of haemodialysis on hepatocyte growth factor level in diabetic patients with chronic renal failure

Influence of recombinant human erythropoietin therapy on plasma level of insulin-like growth factor type 1 (IGF-1) in chronic hemodialysis patients.

Glycated albumin versus glycated hemoglobin in diabetic patients with chronic kidney disease

Treatment of anaemia in patients on regularhaemodialysis : Different modalities

Effect of recombinant human erythropoietin on the parathyroid function and bone density in uremic patients under regular hemodialysis

Study of vitamin E level in haemodialysis patients

Homocysteine level in diabetic and non-diabetic patients maintained on regular haemodialysis

Effect of hemodialysis and renal trasplantation on plasma apelin level in end stage renal disease patients

CMV seropositivity determines Epoetin dose and hemoglobin levels in patients with CKD